Zidovudine, also known as azidothymidine or AZT, is an antiretroviral medication used to treat HIV/AIDS. It is used in combination with other medications to help slow the progression of HIV infection. It works by blocking the action of reverse transcriptase, an enzyme used in the replication of HIV, and thus prevents the virus from multiplying. Zidovudine is generally well tolerated, though it may cause side effects such as nausea, vomiting, headache, and anemia.
Zidovudine, also known by the brand name Retrovir, is a medication used to treat HIV infection. Here's a closer look at its properties:
Function:
- Classified as a nucleoside reverse transcriptase inhibitor (NRTI).
- HIV uses an enzyme called reverse transcriptase to copy its genetic material (RNA) into human cells (DNA) for replication.
- Zidovudine works by interfering with this process, essentially blocking the enzyme and hindering HIV's ability to multiply.
Applications:
- Primarily used in combination with other antiretroviral medications for HIV treatment. This combination approach helps prevent the development of resistance by the virus.
- Can also be used to reduce the risk of mother-to-child transmission of HIV during pregnancy, childbirth, and breastfeeding.
Dosage and Administration:
- Zidovudine comes in capsule, tablet, and syrup forms, taken orally.
- The specific dosage and frequency depend on various factors like age, overall health, and whether it's used for treatment or prevention.
Benefits:
- Plays a crucial role in suppressing HIV replication, slowing down disease progression, and improving the immune system's function.
- Effective in reducing the risk of mother-to-child transmission of HIV when used as part of a preventive regimen.
Considerations:
- Zidovudine can cause side effects, including nausea, headache, fatigue, and anemia (low red blood cell count).
- Regular blood tests are necessary to monitor blood cell counts.
- Zidovudine is not a cure for HIV, but it can significantly improve the quality of life for people living with the virus.
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AF Nucleoside and nucleotide reverse-transcriptase inhibitors
ATC Code
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
ATC Code
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
ATC Code
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J05 Antivirals for systemic use
J05A - Direct acting antiviral drugs
J05AR Antivirals for treatment of HIV infections, combinations
ATC Code
External Links
Zidovudine